In:
Cancer, Wiley, Vol. 122, No. 19 ( 2016-10), p. 3005-3014
Abstract:
FMS‐like tyrosine kinase 3 (FLT3) mutation status does not have an impact on overall survival after allogeneic hematopoietic stem cell transplantation. Pre‐emptive strategies to reduce relapse need to be investigated in patients who have FLT3 mutations to further improve outcomes after hematopoietic stem cell transplantation.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v122.19
Language:
English
Publisher:
Wiley
Publication Date:
2016
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1